Brief: Panbela Therapeutics Inc - On Feb 9, Co Received Formal Notice From Nasdaq Stating That Co’S Scheduled Hearing Has Been Canceled
Panbela Therapeutics Inc PBLA.O :
* PANBELA THERAPEUTICS INC - ON FEB 9, CO RECEIVED FORMAL
NOTICE
FROM NASDAQ STATING THAT CO’S SCHEDULED HEARING HAS BEEN
CANCELED
Source text for Eikon: ID:
Further company coverage: PBLA.O
Recent news on Panbela Therapeutics
See all newsBrief: Panbela Therapeutics Announces Third Independent Safety Review Of Phase 3 Aspire Clinical Trial DSMB Recommended Continuation With No Trial Modification
Brief: Nasdaq Notifies Panbela Therapeutics Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard
Brief: Panbela Announces Pricing of Approximately $9 Mln Public Offering
U.S. STOCKS ON THE MOVE-Fisker, Best Buy, NuStar Energy
Brief: Panbela Therapeutics Announces Exercise Of Warrants And Issuance Of New Warrants